✦ LIBER ✦

Outcome measure for SMA II and III patients

✍ Scribed by Carole Bérard; Jacques Fermanian; Christine Payan

Book ID: 116793407
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 75 KB
Volume: 18
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2008.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to “Response to ‘Outcome measure

Erratum to “Response to ‘Outcome measure for SMA II and III patients’” [Neuromuscul Disord 18 (2008) 594–595]

✍ J. O’Hagen; A. Glanzman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

G.P.4.01 Is assessment of respiratory fu

G.P.4.01 Is assessment of respiratory function a good outcome measure for SMA II and III?

✍ M. Guglieri; M. Eagle; M. McCallum; K. Bushby; V. Straub 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

An expanded version of the Hammersmith F

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

✍ Jessica M. O’Hagen; Allan M. Glanzman; Michael P. McDermott; Patricia A. Ryan; J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 115 KB

N.P.4 01 Relationship between outcome me

N.P.4 01 Relationship between outcome measures assessing strength and function in children with spinal muscular atrophy (SMA) type II and III

✍ K.J. Krosschell; C. Scott; J.A. Maczulski; K.J. Swoboda 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 43 KB

P3.3 Does muscle strength deteriorate ov

P3.3 Does muscle strength deteriorate over time in Spinal muscular atrophy type II and III? Fifteen years follow up study in 22 patients with SMA II and 9 patients with SMA III

✍ U. Werlauff; J. Vissing; B.F. Steffensen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

MCMI-III as a treatment outcome measure

MCMI-III as a treatment outcome measure for psychiatric inpatients

✍ Harry L. Piersma; Janna L. Boes 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

The Million Clinical Multiaxial Inventory-III (MCMI-III) recently was introduced to replace and update the MCMI-II. A sample of 97 psychiatric inpatients were administered the MCMI-III shortly following admission, and again 7-10 days later. Changes in the personality and symptom scales generally par